| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Always randomize as late as possible
|
Werkhoven, Erik van
|
|
2019
|
22 |
6 |
p. 1308-1309
|
artikel
|
| 2 |
Always randomize as late as possible
|
van Werkhoven, Erik
|
|
|
22 |
6 |
p. 1308-1309
|
artikel
|
| 3 |
An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis
|
Katayama, Hiroshi
|
|
2019
|
22 |
6 |
p. 1301-1307
|
artikel
|
| 4 |
An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis
|
Katayama, Hiroshi
|
|
|
22 |
6 |
p. 1301-1307
|
artikel
|
| 5 |
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer
|
Kim, Tae-Yong
|
|
2019
|
22 |
6 |
p. 1206-1214
|
artikel
|
| 6 |
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer
|
Kim, Tae-Yong
|
|
|
22 |
6 |
p. 1206-1214
|
artikel
|
| 7 |
A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer
|
Zhao, Xiaohui
|
|
2019
|
22 |
6 |
p. 1121-1129
|
artikel
|
| 8 |
A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer
|
Zhao, Xiaohui
|
|
|
22 |
6 |
p. 1121-1129
|
artikel
|
| 9 |
Comment on: “Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features. Gastric Cancer, 2019: 1–10” by Wang et al.
|
Yu, Chaoran
|
|
2019
|
22 |
6 |
p. 1312
|
artikel
|
| 10 |
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study
|
Solaini, Leonardo
|
|
2019
|
22 |
6 |
p. 1285-1293
|
artikel
|
| 11 |
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study
|
Solaini, Leonardo
|
|
|
22 |
6 |
p. 1285-1293
|
artikel
|
| 12 |
Correction to: KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study
|
Hewitt, Lindsay C.
|
|
2019
|
22 |
6 |
p. 1204-1205
|
artikel
|
| 13 |
Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset
|
Nakanishi, Koki
|
|
2019
|
22 |
6 |
p. 1215-1225
|
artikel
|
| 14 |
Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset
|
Nakanishi, Koki
|
|
|
22 |
6 |
p. 1215-1225
|
artikel
|
| 15 |
Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact
|
Kim, Joo Yeon
|
|
2019
|
22 |
6 |
p. 1164-1175
|
artikel
|
| 16 |
Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact
|
Kim, Joo Yeon
|
|
|
22 |
6 |
p. 1164-1175
|
artikel
|
| 17 |
Different phenotypes of gastric fundic gland polyposis and cancer in patients with familial adenomatous polyposis depending on Helicobacter pylori infection
|
Mitsui, Yasuhiro
|
|
2019
|
22 |
6 |
p. 1294-1300
|
artikel
|
| 18 |
Different phenotypes of gastric fundic gland polyposis and cancer in patients with familial adenomatous polyposis depending on Helicobacter pylori infection
|
Mitsui, Yasuhiro
|
|
|
22 |
6 |
p. 1294-1300
|
artikel
|
| 19 |
DNA methylation genome-wide analysis in remnant and primary gastric cancers
|
Sugimoto, Kiichi
|
|
2019
|
22 |
6 |
p. 1109-1120
|
artikel
|
| 20 |
DNA methylation genome-wide analysis in remnant and primary gastric cancers
|
Sugimoto, Kiichi
|
|
|
22 |
6 |
p. 1109-1120
|
artikel
|
| 21 |
Does neoadjuvant chemotherapy cancel out the negative survival impact induced by surgical complications after gastrectomy?
|
Hayashi, Masato
|
|
2019
|
22 |
6 |
p. 1274-1284
|
artikel
|
| 22 |
Does neoadjuvant chemotherapy cancel out the negative survival impact induced by surgical complications after gastrectomy?
|
Hayashi, Masato
|
|
|
22 |
6 |
p. 1274-1284
|
artikel
|
| 23 |
Genetic variations associated with telomere length confer risk of gastric cardia adenocarcinoma
|
Zhang, Nasha
|
|
2019
|
22 |
6 |
p. 1089-1099
|
artikel
|
| 24 |
Genetic variations associated with telomere length confer risk of gastric cardia adenocarcinoma
|
Zhang, Nasha
|
|
|
22 |
6 |
p. 1089-1099
|
artikel
|
| 25 |
Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features
|
Wang, Yakun
|
|
2019
|
22 |
6 |
p. 1183-1192
|
artikel
|
| 26 |
Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer
|
Jung, Minkyu
|
|
2019
|
22 |
6 |
p. 1153-1163
|
artikel
|
| 27 |
Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer
|
Jung, Minkyu
|
|
|
22 |
6 |
p. 1153-1163
|
artikel
|
| 28 |
KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study
|
Hewitt, Lindsay C.
|
|
2019
|
22 |
6 |
p. 1193-1203
|
artikel
|
| 29 |
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer
|
Takahari, Daisuke
|
|
2019
|
22 |
6 |
p. 1238-1246
|
artikel
|
| 30 |
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer
|
Takahari, Daisuke
|
|
|
22 |
6 |
p. 1238-1246
|
artikel
|
| 31 |
Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study
|
Mokadem, I.
|
|
2019
|
22 |
6 |
p. 1263-1273
|
artikel
|
| 32 |
Report about the present condition of Billroth’s stomach specimens
|
Sato, Hiroshi
|
|
2019
|
22 |
6 |
p. 1310-1311
|
artikel
|
| 33 |
Report about the present condition of Billroth’s stomach specimens
|
Sato, Hiroshi
|
|
|
22 |
6 |
p. 1310-1311
|
artikel
|
| 34 |
Risk stratification for lymph node metastasis using Epstein–Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study
|
Osumi, Hiroki
|
|
2019
|
22 |
6 |
p. 1176-1182
|
artikel
|
| 35 |
Risk stratification for lymph node metastasis using Epstein–Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study
|
Osumi, Hiroki
|
|
|
22 |
6 |
p. 1176-1182
|
artikel
|
| 36 |
Should pylorus-preserving gastrectomy be performed for overweight/obese patients with gastric cancer?
|
Tsujiura, Masahiro
|
|
2019
|
22 |
6 |
p. 1247-1255
|
artikel
|
| 37 |
Should pylorus-preserving gastrectomy be performed for overweight/obese patients with gastric cancer?
|
Tsujiura, Masahiro
|
|
|
22 |
6 |
p. 1247-1255
|
artikel
|
| 38 |
The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis
|
Rau, Beate
|
|
2019
|
22 |
6 |
p. 1226-1237
|
artikel
|
| 39 |
The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis
|
Rau, Beate
|
|
|
22 |
6 |
p. 1226-1237
|
artikel
|
| 40 |
The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications
|
Heckl, Steffen M.
|
|
2019
|
22 |
6 |
p. 1130-1142
|
artikel
|
| 41 |
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
|
Nakanishi, Koki
|
|
2019
|
22 |
6 |
p. 1143-1152
|
artikel
|
| 42 |
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
|
Nakanishi, Koki
|
|
|
22 |
6 |
p. 1143-1152
|
artikel
|
| 43 |
The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors
|
Koga, Yuki
|
|
2019
|
22 |
6 |
p. 1100-1108
|
artikel
|
| 44 |
The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors
|
Koga, Yuki
|
|
|
22 |
6 |
p. 1100-1108
|
artikel
|
| 45 |
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy
|
Takahashi, Ryo
|
|
2019
|
22 |
6 |
p. 1256-1262
|
artikel
|
| 46 |
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy
|
Takahashi, Ryo
|
|
|
22 |
6 |
p. 1256-1262
|
artikel
|
Tijdschrift beschrijving